{"id":"W2518726365","doi":"10.1161/jaha.116.003421","title":"Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study","year":2016,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"Amgen; Daiichi-Sankyo; Regeneron Pharmaceuticals; Sanofi; Daiichi Sankyo Europe; Eli Lilly and Company","keywords":"Medicine; Alirocumab; Familial hypercholesterolemia; Statin; Ldl cholesterol; PCSK9; Atherosclerotic cardiovascular disease; Internal medicine; Cholesterol; LDL receptor; Total cholesterol; Lipoprotein; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00182454,0.0001064101,0.0005400228,0.0000706636,0.0001056349,0.000009549916,0.00009718402,0.00002946454,0.000003345995],"category_scores_gemma":[0.0004719348,0.00004339681,0.000131259,0.0002304273,0.00005305763,0.00008521826,0.00003211024,0.0002650851,7.567355e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003853721,"about_ca_system_score_gemma":0.0001262833,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003310951,"about_ca_topic_score_gemma":0.00003602232,"domain_scores_codex":[0.9977319,0.0006202836,0.0004253168,0.0001132599,0.0009442742,0.0001650257],"domain_scores_gemma":[0.9983712,0.0003906479,0.0006688508,0.0002887172,0.0002302952,0.00005032859],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00264836,0.0005386022,0.9522203,0.000005014997,0.0002829733,6.836462e-7,0.000789262,0.000009774986,0.0006345834,7.250534e-7,0.0001199953,0.04274973],"study_design_scores_gemma":[0.009470709,0.004901814,0.9838024,0.0001840644,0.0000886664,0.000004142963,0.0002487484,0.000001324004,0.0001624193,0.000003564551,0.001079514,0.00005258826],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994359,0.00005126212,0.000006522681,0.004827783,0.0000649393,0.0006662193,0.000006160737,0.000003383851,0.00001475548],"genre_scores_gemma":[0.9985484,0.0000930632,0.00003805655,0.001131454,0.0001124038,0.000004556206,3.272206e-7,0.00001468962,0.00005703215],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04269714,"threshold_uncertainty_score":0.176967,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01026542998422311,"score_gpt":0.2648552904499377,"score_spread":0.2545898604657146,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}